nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PTGS1—Montelukast—allergic rhinitis	0.0472	0.0775	CbGbCtD
Bortezomib—PTGS1—Diphenhydramine—allergic rhinitis	0.0472	0.0775	CbGbCtD
Bortezomib—CYP2C19—Desloratadine—allergic rhinitis	0.0398	0.0653	CbGbCtD
Bortezomib—CYP1A2—Desloratadine—allergic rhinitis	0.0367	0.0603	CbGbCtD
Bortezomib—CYP2C9—Desloratadine—allergic rhinitis	0.0331	0.0543	CbGbCtD
Bortezomib—CYP2D6—Desloratadine—allergic rhinitis	0.0302	0.0497	CbGbCtD
Bortezomib—CYP2C8—Montelukast—allergic rhinitis	0.0272	0.0447	CbGbCtD
Bortezomib—CYP2C8—Loratadine—allergic rhinitis	0.0272	0.0447	CbGbCtD
Bortezomib—CYP2C19—Loratadine—allergic rhinitis	0.0228	0.0375	CbGbCtD
Bortezomib—CYP2C19—Diphenhydramine—allergic rhinitis	0.0228	0.0375	CbGbCtD
Bortezomib—CYP1A2—Diphenhydramine—allergic rhinitis	0.0211	0.0346	CbGbCtD
Bortezomib—CYP3A4—Flunisolide—allergic rhinitis	0.0192	0.0316	CbGbCtD
Bortezomib—CYP2C9—Montelukast—allergic rhinitis	0.019	0.0312	CbGbCtD
Bortezomib—CYP2C9—Loratadine—allergic rhinitis	0.019	0.0312	CbGbCtD
Bortezomib—CYP2C9—Diphenhydramine—allergic rhinitis	0.019	0.0312	CbGbCtD
Bortezomib—CYP3A4—Olopatadine—allergic rhinitis	0.0181	0.0297	CbGbCtD
Bortezomib—CYP2D6—Diphenhydramine—allergic rhinitis	0.0174	0.0285	CbGbCtD
Bortezomib—CYP2D6—Loratadine—allergic rhinitis	0.0174	0.0285	CbGbCtD
Bortezomib—CYP1A1—Dexamethasone—allergic rhinitis	0.0163	0.0268	CbGbCtD
Bortezomib—CYP2C8—Hydrocortisone—allergic rhinitis	0.0151	0.0249	CbGbCtD
Bortezomib—CYP3A4—Loratadine—allergic rhinitis	0.011	0.0181	CbGbCtD
Bortezomib—CYP3A4—Montelukast—allergic rhinitis	0.011	0.0181	CbGbCtD
Bortezomib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0101	0.0166	CbGbCtD
Bortezomib—CYP2C8—Dexamethasone—allergic rhinitis	0.00942	0.0155	CbGbCtD
Bortezomib—CYP2C19—Dexamethasone—allergic rhinitis	0.0079	0.013	CbGbCtD
Bortezomib—CYP3A4—Triamcinolone—allergic rhinitis	0.00765	0.0126	CbGbCtD
Bortezomib—CYP2C9—Dexamethasone—allergic rhinitis	0.00657	0.0108	CbGbCtD
Bortezomib—CYP3A4—Betamethasone—allergic rhinitis	0.00657	0.0108	CbGbCtD
Bortezomib—CYP3A4—Prednisolone—allergic rhinitis	0.00648	0.0106	CbGbCtD
Bortezomib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00614	0.0101	CbGbCtD
Bortezomib—CYP2D6—Dexamethasone—allergic rhinitis	0.00601	0.00987	CbGbCtD
Bortezomib—CTSG—respiratory system—allergic rhinitis	0.00427	0.0437	CbGeAlD
Bortezomib—PSMA1—respiratory system—allergic rhinitis	0.0041	0.0419	CbGeAlD
Bortezomib—CYP3A4—Dexamethasone—allergic rhinitis	0.00382	0.00628	CbGbCtD
Bortezomib—PSMA1—epithelium—allergic rhinitis	0.00343	0.035	CbGeAlD
Bortezomib—CTSG—skin of body—allergic rhinitis	0.0034	0.0347	CbGeAlD
Bortezomib—PSMA1—skin of body—allergic rhinitis	0.00326	0.0333	CbGeAlD
Bortezomib—CTSG—trachea—allergic rhinitis	0.00316	0.0323	CbGeAlD
Bortezomib—PSMD1—eye—allergic rhinitis	0.00315	0.0322	CbGeAlD
Bortezomib—PSMD2—respiratory system—allergic rhinitis	0.00305	0.0312	CbGeAlD
Bortezomib—PSMD1—bronchus—allergic rhinitis	0.00284	0.029	CbGeAlD
Bortezomib—PSMD2—eye—allergic rhinitis	0.00279	0.0285	CbGeAlD
Bortezomib—PSMD1—trachea—allergic rhinitis	0.00255	0.026	CbGeAlD
Bortezomib—PSMD2—bronchus—allergic rhinitis	0.00251	0.0257	CbGeAlD
Bortezomib—PSMB8—bronchus—allergic rhinitis	0.0025	0.0255	CbGeAlD
Bortezomib—PSMD2—skin of body—allergic rhinitis	0.00243	0.0248	CbGeAlD
Bortezomib—PSMB1—respiratory system—allergic rhinitis	0.00234	0.0239	CbGeAlD
Bortezomib—PSMB2—respiratory system—allergic rhinitis	0.00229	0.0233	CbGeAlD
Bortezomib—CTSG—lung—allergic rhinitis	0.00227	0.0232	CbGeAlD
Bortezomib—PSMD2—trachea—allergic rhinitis	0.00226	0.023	CbGeAlD
Bortezomib—PSMB8—trachea—allergic rhinitis	0.00224	0.0229	CbGeAlD
Bortezomib—PSMB5—bronchus—allergic rhinitis	0.00221	0.0225	CbGeAlD
Bortezomib—PSMA1—lung—allergic rhinitis	0.00218	0.0223	CbGeAlD
Bortezomib—PSMB1—eye—allergic rhinitis	0.00214	0.0219	CbGeAlD
Bortezomib—PSMB2—eye—allergic rhinitis	0.00209	0.0213	CbGeAlD
Bortezomib—PSMB5—trachea—allergic rhinitis	0.00198	0.0202	CbGeAlD
Bortezomib—SLC31A1—respiratory system—allergic rhinitis	0.00198	0.0202	CbGeAlD
Bortezomib—PSMB1—bronchus—allergic rhinitis	0.00193	0.0197	CbGeAlD
Bortezomib—PSMB2—bronchus—allergic rhinitis	0.00188	0.0192	CbGeAlD
Bortezomib—PSMB1—skin of body—allergic rhinitis	0.00186	0.019	CbGeAlD
Bortezomib—PSMD1—lung—allergic rhinitis	0.00183	0.0187	CbGeAlD
Bortezomib—PSMB2—skin of body—allergic rhinitis	0.00182	0.0186	CbGeAlD
Bortezomib—PSMB1—trachea—allergic rhinitis	0.00173	0.0177	CbGeAlD
Bortezomib—PSMB2—trachea—allergic rhinitis	0.00169	0.0172	CbGeAlD
Bortezomib—SLC31A1—bronchus—allergic rhinitis	0.00163	0.0166	CbGeAlD
Bortezomib—PSMD2—lung—allergic rhinitis	0.00162	0.0166	CbGeAlD
Bortezomib—PSMB8—lung—allergic rhinitis	0.00161	0.0165	CbGeAlD
Bortezomib—SLC31A1—trachea—allergic rhinitis	0.00146	0.0149	CbGeAlD
Bortezomib—PSMB5—lung—allergic rhinitis	0.00142	0.0145	CbGeAlD
Bortezomib—PSMB1—lung—allergic rhinitis	0.00124	0.0127	CbGeAlD
Bortezomib—PSMB2—lung—allergic rhinitis	0.00121	0.0124	CbGeAlD
Bortezomib—SLC31A1—lung—allergic rhinitis	0.00105	0.0107	CbGeAlD
Bortezomib—PSMB8—Metixene—Cyproheptadine—allergic rhinitis	0.000917	0.155	CbGdCrCtD
Bortezomib—PSMB2—Proteasome Degradation—HLA-G—allergic rhinitis	0.000686	0.0181	CbGpPWpGaD
Bortezomib—CYP1A2—respiratory system—allergic rhinitis	0.000681	0.00696	CbGeAlD
Bortezomib—PSMB2—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.000678	0.0178	CbGpPWpGaD
Bortezomib—PSMB5—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.000678	0.0178	CbGpPWpGaD
Bortezomib—PSMB1—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.000678	0.0178	CbGpPWpGaD
Bortezomib—PSMB8—Proteasome Degradation—HLA-G—allergic rhinitis	0.000677	0.0178	CbGpPWpGaD
Bortezomib—CYP1A1—respiratory system—allergic rhinitis	0.000672	0.00687	CbGeAlD
Bortezomib—PSMB8—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.000668	0.0176	CbGpPWpGaD
Bortezomib—PSMB8—Interferon alpha/beta signaling—HLA-G—allergic rhinitis	0.000652	0.0172	CbGpPWpGaD
Bortezomib—PTGS1—respiratory system—allergic rhinitis	0.00059	0.00603	CbGeAlD
Bortezomib—CYP1A1—epithelium—allergic rhinitis	0.000562	0.00574	CbGeAlD
Bortezomib—PSMB5—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00056	0.0147	CbGpPWpGaD
Bortezomib—PSMB1—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00056	0.0147	CbGpPWpGaD
Bortezomib—PSMB2—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00056	0.0147	CbGpPWpGaD
Bortezomib—CYP1A1—bronchus—allergic rhinitis	0.000553	0.00565	CbGeAlD
Bortezomib—PSMB8—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.000552	0.0145	CbGpPWpGaD
Bortezomib—CYP1A1—skin of body—allergic rhinitis	0.000534	0.00546	CbGeAlD
Bortezomib—CYP1A1—trachea—allergic rhinitis	0.000497	0.00507	CbGeAlD
Bortezomib—PTGS1—epithelium—allergic rhinitis	0.000493	0.00504	CbGeAlD
Bortezomib—PTGS1—skin of body—allergic rhinitis	0.000469	0.00479	CbGeAlD
Bortezomib—PTGS1—trachea—allergic rhinitis	0.000436	0.00446	CbGeAlD
Bortezomib—CYP1A2—lung—allergic rhinitis	0.000362	0.0037	CbGeAlD
Bortezomib—PSMA1—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.00036	0.00948	CbGpPWpGaD
Bortezomib—PSMD1—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.000358	0.00943	CbGpPWpGaD
Bortezomib—CYP1A1—lung—allergic rhinitis	0.000357	0.00365	CbGeAlD
Bortezomib—PSMD2—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.000357	0.00939	CbGpPWpGaD
Bortezomib—PSMD2—Fluticasone Propionate—Flunisolide—allergic rhinitis	0.00033	0.0559	CbGdCrCtD
Bortezomib—CTSG—Extracellular matrix organization—ICAM1—allergic rhinitis	0.000315	0.00829	CbGpPWpGaD
Bortezomib—PTGS1—lung—allergic rhinitis	0.000314	0.0032	CbGeAlD
Bortezomib—PSMB8—Interferon Signaling—HLA-G—allergic rhinitis	0.000303	0.00799	CbGpPWpGaD
Bortezomib—PSMA1—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000295	0.00776	CbGpPWpGaD
Bortezomib—PSMD1—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000294	0.00773	CbGpPWpGaD
Bortezomib—PSMD2—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000292	0.00769	CbGpPWpGaD
Bortezomib—PSMB5—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.000273	0.00718	CbGpPWpGaD
Bortezomib—PSMB1—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.000273	0.00718	CbGpPWpGaD
Bortezomib—PSMB2—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.000273	0.00718	CbGpPWpGaD
Bortezomib—PSMB8—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.000269	0.00708	CbGpPWpGaD
Bortezomib—PSMA1—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.000251	0.00662	CbGpPWpGaD
Bortezomib—PSMD1—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.00025	0.00659	CbGpPWpGaD
Bortezomib—PSMD2—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.000249	0.00656	CbGpPWpGaD
Bortezomib—PSMB8—Fluorometholone—Flunisolide—allergic rhinitis	0.000238	0.0403	CbGdCrCtD
Bortezomib—PSMB5—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000224	0.00588	CbGpPWpGaD
Bortezomib—PSMB2—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000224	0.00588	CbGpPWpGaD
Bortezomib—PSMB1—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000224	0.00588	CbGpPWpGaD
Bortezomib—PSMB8—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.00022	0.0058	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000203	0.00533	CbGpPWpGaD
Bortezomib—PSMB1—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.000191	0.00502	CbGpPWpGaD
Bortezomib—PSMB2—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.000191	0.00502	CbGpPWpGaD
Bortezomib—PSMB5—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.000191	0.00502	CbGpPWpGaD
Bortezomib—PSMB8—Interferon Signaling—HLA-DQB1—allergic rhinitis	0.000189	0.00498	CbGpPWpGaD
Bortezomib—PSMD2—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	0.000189	0.00497	CbGpPWpGaD
Bortezomib—PSMB8—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.000188	0.00495	CbGpPWpGaD
Bortezomib—PSMB8—Diflorasone—Flunisolide—allergic rhinitis	0.000181	0.0307	CbGdCrCtD
Bortezomib—PSMA1—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000172	0.00452	CbGpPWpGaD
Bortezomib—PSMD1—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000171	0.0045	CbGpPWpGaD
Bortezomib—PSMD2—Host Interactions of HIV factors—CD4—allergic rhinitis	0.00017	0.00448	CbGpPWpGaD
Bortezomib—PSMB8—Medrysone—Hydrocortisone—allergic rhinitis	0.00017	0.0288	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Flunisolide—allergic rhinitis	0.000167	0.0283	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Flunisolide—allergic rhinitis	0.000167	0.0283	CbGdCrCtD
Bortezomib—CTSG—Extracellular matrix organization—TGFB1—allergic rhinitis	0.000166	0.00437	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—MS4A2—allergic rhinitis	0.000164	0.00432	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000163	0.0043	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—MS4A2—allergic rhinitis	0.000163	0.0043	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—MS4A2—allergic rhinitis	0.000162	0.00428	CbGpPWpGaD
Bortezomib—PSMD2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	0.000161	0.0274	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Methylprednisolone—allergic rhinitis	0.000161	0.0272	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	0.000159	0.0269	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Betamethasone—allergic rhinitis	0.000159	0.0269	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	0.000155	0.0263	CbGdCrCtD
Bortezomib—PSMA1—Adaptive Immune System—HLA-G—allergic rhinitis	0.000146	0.00384	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—HLA-G—allergic rhinitis	0.000145	0.00382	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—HLA-G—allergic rhinitis	0.000145	0.00381	CbGpPWpGaD
Bortezomib—PSMB8—Medrysone—Prednisolone—allergic rhinitis	0.000143	0.0242	CbGdCrCtD
Bortezomib—PSMB8—Interferon Signaling—ICAM1—allergic rhinitis	0.000138	0.00364	CbGpPWpGaD
Bortezomib—CYP1A1—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000134	0.00352	CbGpPWpGaD
Bortezomib—CYP1A1—Oxidative Stress—NFKB1—allergic rhinitis	0.00013	0.00343	CbGpPWpGaD
Bortezomib—PSMB5—Host Interactions of HIV factors—CD4—allergic rhinitis	0.00013	0.00343	CbGpPWpGaD
Bortezomib—PSMB1—Host Interactions of HIV factors—CD4—allergic rhinitis	0.00013	0.00343	CbGpPWpGaD
Bortezomib—PSMB2—Host Interactions of HIV factors—CD4—allergic rhinitis	0.00013	0.00343	CbGpPWpGaD
Bortezomib—PSMB8—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000128	0.00338	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000126	0.00333	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—MS4A2—allergic rhinitis	0.000124	0.00327	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—MS4A2—allergic rhinitis	0.000124	0.00327	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—MS4A2—allergic rhinitis	0.000124	0.00327	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000123	0.00325	CbGpPWpGaD
Bortezomib—PSMB8—Fluorometholone—Hydrocortisone—allergic rhinitis	0.000123	0.0209	CbGdCrCtD
Bortezomib—PSMB8—Immune System—MS4A2—allergic rhinitis	0.000123	0.00323	CbGpPWpGaD
Bortezomib—PSMA1—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000118	0.00311	CbGpPWpGaD
Bortezomib—PSMD1—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000118	0.0031	CbGpPWpGaD
Bortezomib—PSMD2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000117	0.00308	CbGpPWpGaD
Bortezomib—PSMB8—Fluorometholone—Methylprednisolone—allergic rhinitis	0.000116	0.0197	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Betamethasone—allergic rhinitis	0.000114	0.0194	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Dexamethasone—allergic rhinitis	0.000114	0.0194	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Triamcinolone—allergic rhinitis	0.000112	0.0189	CbGdCrCtD
Bortezomib—PSMA1—HIV Infection—CD4—allergic rhinitis	0.000112	0.00294	CbGpPWpGaD
Bortezomib—PSMD1—HIV Infection—CD4—allergic rhinitis	0.000111	0.00293	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—HLA-G—allergic rhinitis	0.000111	0.00291	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—HLA-G—allergic rhinitis	0.000111	0.00291	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—HLA-G—allergic rhinitis	0.000111	0.00291	CbGpPWpGaD
Bortezomib—PSMD2—HIV Infection—CD4—allergic rhinitis	0.000111	0.00291	CbGpPWpGaD
Bortezomib—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.00011	0.00288	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—HLA-G—allergic rhinitis	0.000109	0.00287	CbGpPWpGaD
Bortezomib—PSMA1—B Cell Activation—NFKB1—allergic rhinitis	0.000104	0.00275	CbGpPWpGaD
Bortezomib—PSMD1—B Cell Activation—NFKB1—allergic rhinitis	0.000104	0.00274	CbGpPWpGaD
Bortezomib—PSMB8—Fluorometholone—Prednisolone—allergic rhinitis	0.000104	0.0175	CbGdCrCtD
Bortezomib—PSMD2—B Cell Activation—NFKB1—allergic rhinitis	0.000103	0.00272	CbGpPWpGaD
Bortezomib—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000101	0.00265	CbGpPWpGaD
Bortezomib—PSMB8—Dexamethasone—Flunisolide—allergic rhinitis	9.7e-05	0.0164	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Flunisolide—allergic rhinitis	9.7e-05	0.0164	CbGdCrCtD
Bortezomib—PSMB8—Testosterone Propionate—Hydrocortisone—allergic rhinitis	9.48e-05	0.0161	CbGdCrCtD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	9.26e-05	0.00244	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	9.23e-05	0.00243	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	9.11e-05	0.0024	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	9.07e-05	0.00239	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	9.02e-05	0.00238	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—PTGDR2—allergic rhinitis	9.01e-05	0.00237	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—PTGDR2—allergic rhinitis	8.97e-05	0.00236	CbGpPWpGaD
Bortezomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	8.96e-05	0.00236	CbGpPWpGaD
Bortezomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	8.96e-05	0.00236	CbGpPWpGaD
Bortezomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	8.96e-05	0.00236	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—PTGDR2—allergic rhinitis	8.93e-05	0.00235	CbGpPWpGaD
Bortezomib—PSMB8—Diflorasone—Methylprednisolone—allergic rhinitis	8.85e-05	0.015	CbGdCrCtD
Bortezomib—PSMA1—Immune System—HLA-G—allergic rhinitis	8.85e-05	0.00233	CbGpPWpGaD
Bortezomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	8.83e-05	0.00232	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HLA-G—allergic rhinitis	8.81e-05	0.00232	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-G—allergic rhinitis	8.77e-05	0.00231	CbGpPWpGaD
Bortezomib—PSMB8—Diflorasone—Betamethasone—allergic rhinitis	8.71e-05	0.0148	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Dexamethasone—allergic rhinitis	8.71e-05	0.0148	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Hydrocortisone—allergic rhinitis	8.67e-05	0.0147	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Hydrocortisone—allergic rhinitis	8.67e-05	0.0147	CbGdCrCtD
Bortezomib—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	8.54e-05	0.00225	CbGpPWpGaD
Bortezomib—PSMB8—Diflorasone—Triamcinolone—allergic rhinitis	8.51e-05	0.0144	CbGdCrCtD
Bortezomib—PSMB2—HIV Infection—CD4—allergic rhinitis	8.46e-05	0.00223	CbGpPWpGaD
Bortezomib—PSMB1—HIV Infection—CD4—allergic rhinitis	8.46e-05	0.00223	CbGpPWpGaD
Bortezomib—PSMB5—HIV Infection—CD4—allergic rhinitis	8.46e-05	0.00223	CbGpPWpGaD
Bortezomib—PSMB8—HIV Infection—CD4—allergic rhinitis	8.34e-05	0.0022	CbGpPWpGaD
Bortezomib—PSMD2—Dexamethasone—Methylprednisolone—allergic rhinitis	8.18e-05	0.0139	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Methylprednisolone—allergic rhinitis	8.18e-05	0.0139	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Dexamethasone—allergic rhinitis	8.06e-05	0.0136	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Betamethasone—allergic rhinitis	8.06e-05	0.0136	CbGdCrCtD
Bortezomib—PSMB2—B Cell Activation—NFKB1—allergic rhinitis	7.91e-05	0.00208	CbGpPWpGaD
Bortezomib—PSMB5—B Cell Activation—NFKB1—allergic rhinitis	7.91e-05	0.00208	CbGpPWpGaD
Bortezomib—PSMB1—B Cell Activation—NFKB1—allergic rhinitis	7.91e-05	0.00208	CbGpPWpGaD
Bortezomib—PSMB8—Diflorasone—Prednisolone—allergic rhinitis	7.89e-05	0.0134	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Triamcinolone—allergic rhinitis	7.87e-05	0.0133	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Triamcinolone—allergic rhinitis	7.87e-05	0.0133	CbGdCrCtD
Bortezomib—PTGS1—Selenium Micronutrient Network—NFKB1—allergic rhinitis	7.82e-05	0.00206	CbGpPWpGaD
Bortezomib—PSMB8—B Cell Activation—NFKB1—allergic rhinitis	7.8e-05	0.00205	CbGpPWpGaD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	7.71e-05	0.00203	CbGpPWpGaD
Bortezomib—PSMD2—Dexamethasone—Prednisolone—allergic rhinitis	7.29e-05	0.0124	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Prednisolone—allergic rhinitis	7.29e-05	0.0124	CbGdCrCtD
Bortezomib—PSMA1—Immune System—IL5—allergic rhinitis	7.14e-05	0.00188	CbGpPWpGaD
Bortezomib—PSMB8—Norethindrone—Hydrocortisone—allergic rhinitis	7.1e-05	0.012	CbGdCrCtD
Bortezomib—PSMD1—Immune System—IL5—allergic rhinitis	7.1e-05	0.00187	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CYSLTR1—allergic rhinitis	7.07e-05	0.00186	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL5—allergic rhinitis	7.07e-05	0.00186	CbGpPWpGaD
Bortezomib—Headache—Montelukast—allergic rhinitis	7.06e-05	0.000283	CcSEcCtD
Bortezomib—Visual impairment—Dexamethasone—allergic rhinitis	7.06e-05	0.000283	CcSEcCtD
Bortezomib—Visual impairment—Betamethasone—allergic rhinitis	7.06e-05	0.000283	CcSEcCtD
Bortezomib—Mental disorder—Methylprednisolone—allergic rhinitis	7.05e-05	0.000283	CcSEcCtD
Bortezomib—PSMD1—Signaling Pathways—CYSLTR1—allergic rhinitis	7.04e-05	0.00185	CbGpPWpGaD
Bortezomib—Erythema—Triamcinolone—allergic rhinitis	7.02e-05	0.000281	CcSEcCtD
Bortezomib—Erythema—Methylprednisolone—allergic rhinitis	7.01e-05	0.000281	CcSEcCtD
Bortezomib—Malnutrition—Methylprednisolone—allergic rhinitis	7.01e-05	0.000281	CcSEcCtD
Bortezomib—PSMD2—Signaling Pathways—CYSLTR1—allergic rhinitis	7.01e-05	0.00184	CbGpPWpGaD
Bortezomib—Angioedema—Prednisolone—allergic rhinitis	6.98e-05	0.00028	CcSEcCtD
Bortezomib—Ill-defined disorder—Hydrocortisone—allergic rhinitis	6.92e-05	0.000277	CcSEcCtD
Bortezomib—PSMB2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	6.9e-05	0.00182	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	6.9e-05	0.00182	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—HLA-DQB1—allergic rhinitis	6.9e-05	0.00182	CbGpPWpGaD
Bortezomib—Malaise—Prednisolone—allergic rhinitis	6.89e-05	0.000276	CcSEcCtD
Bortezomib—Dysgeusia—Triamcinolone—allergic rhinitis	6.88e-05	0.000276	CcSEcCtD
Bortezomib—Vertigo—Prednisolone—allergic rhinitis	6.86e-05	0.000275	CcSEcCtD
Bortezomib—Syncope—Prednisolone—allergic rhinitis	6.85e-05	0.000274	CcSEcCtD
Bortezomib—Eye disorder—Dexamethasone—allergic rhinitis	6.84e-05	0.000274	CcSEcCtD
Bortezomib—Eye disorder—Betamethasone—allergic rhinitis	6.84e-05	0.000274	CcSEcCtD
Bortezomib—PSMA1—Signaling Pathways—CCL11—allergic rhinitis	6.83e-05	0.0018	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PTGDR2—allergic rhinitis	6.83e-05	0.0018	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PTGDR2—allergic rhinitis	6.83e-05	0.0018	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PTGDR2—allergic rhinitis	6.83e-05	0.0018	CbGpPWpGaD
Bortezomib—Angioedema—Hydrocortisone—allergic rhinitis	6.82e-05	0.000273	CcSEcCtD
Bortezomib—PSMB8—Adaptive Immune System—HLA-DQB1—allergic rhinitis	6.81e-05	0.00179	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCL11—allergic rhinitis	6.8e-05	0.00179	CbGpPWpGaD
Bortezomib—Back pain—Triamcinolone—allergic rhinitis	6.79e-05	0.000272	CcSEcCtD
Bortezomib—PSMD2—Signaling Pathways—CCL11—allergic rhinitis	6.77e-05	0.00178	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PTGDR2—allergic rhinitis	6.73e-05	0.00177	CbGpPWpGaD
Bortezomib—Malaise—Hydrocortisone—allergic rhinitis	6.73e-05	0.00027	CcSEcCtD
Bortezomib—Loss of consciousness—Prednisolone—allergic rhinitis	6.71e-05	0.000269	CcSEcCtD
Bortezomib—PSMB5—Immune System—HLA-G—allergic rhinitis	6.71e-05	0.00177	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-G—allergic rhinitis	6.71e-05	0.00177	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-G—allergic rhinitis	6.71e-05	0.00177	CbGpPWpGaD
Bortezomib—Vertigo—Hydrocortisone—allergic rhinitis	6.7e-05	0.000269	CcSEcCtD
Bortezomib—Nausea—Montelukast—allergic rhinitis	6.7e-05	0.000268	CcSEcCtD
Bortezomib—Syncope—Hydrocortisone—allergic rhinitis	6.69e-05	0.000268	CcSEcCtD
Bortezomib—PSMA1—Adaptive Immune System—ICAM1—allergic rhinitis	6.65e-05	0.00175	CbGpPWpGaD
Bortezomib—Angiopathy—Dexamethasone—allergic rhinitis	6.64e-05	0.000266	CcSEcCtD
Bortezomib—Angiopathy—Betamethasone—allergic rhinitis	6.64e-05	0.000266	CcSEcCtD
Bortezomib—Convulsion—Prednisolone—allergic rhinitis	6.62e-05	0.000265	CcSEcCtD
Bortezomib—PSMD1—Adaptive Immune System—ICAM1—allergic rhinitis	6.62e-05	0.00174	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HLA-G—allergic rhinitis	6.62e-05	0.00174	CbGpPWpGaD
Bortezomib—Hypertension—Prednisolone—allergic rhinitis	6.59e-05	0.000264	CcSEcCtD
Bortezomib—PSMD2—Adaptive Immune System—ICAM1—allergic rhinitis	6.59e-05	0.00173	CbGpPWpGaD
Bortezomib—Loss of consciousness—Hydrocortisone—allergic rhinitis	6.56e-05	0.000263	CcSEcCtD
Bortezomib—Arrhythmia—Dexamethasone—allergic rhinitis	6.54e-05	0.000262	CcSEcCtD
Bortezomib—Arrhythmia—Betamethasone—allergic rhinitis	6.54e-05	0.000262	CcSEcCtD
Bortezomib—Ill-defined disorder—Triamcinolone—allergic rhinitis	6.52e-05	0.000261	CcSEcCtD
Bortezomib—Ill-defined disorder—Methylprednisolone—allergic rhinitis	6.5e-05	0.000261	CcSEcCtD
Bortezomib—Convulsion—Hydrocortisone—allergic rhinitis	6.46e-05	0.000259	CcSEcCtD
Bortezomib—Hypertension—Hydrocortisone—allergic rhinitis	6.44e-05	0.000258	CcSEcCtD
Bortezomib—Discomfort—Prednisolone—allergic rhinitis	6.42e-05	0.000257	CcSEcCtD
Bortezomib—Angioedema—Triamcinolone—allergic rhinitis	6.42e-05	0.000257	CcSEcCtD
Bortezomib—Angioedema—Methylprednisolone—allergic rhinitis	6.4e-05	0.000257	CcSEcCtD
Bortezomib—Erythema—Betamethasone—allergic rhinitis	6.37e-05	0.000255	CcSEcCtD
Bortezomib—Erythema—Dexamethasone—allergic rhinitis	6.37e-05	0.000255	CcSEcCtD
Bortezomib—Myalgia—Hydrocortisone—allergic rhinitis	6.35e-05	0.000254	CcSEcCtD
Bortezomib—Malaise—Triamcinolone—allergic rhinitis	6.33e-05	0.000254	CcSEcCtD
Bortezomib—Anxiety—Hydrocortisone—allergic rhinitis	6.33e-05	0.000254	CcSEcCtD
Bortezomib—Malaise—Methylprednisolone—allergic rhinitis	6.32e-05	0.000253	CcSEcCtD
Bortezomib—Vertigo—Triamcinolone—allergic rhinitis	6.31e-05	0.000253	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	6.31e-05	0.000253	CcSEcCtD
Bortezomib—Syncope—Triamcinolone—allergic rhinitis	6.3e-05	0.000252	CcSEcCtD
Bortezomib—Vertigo—Methylprednisolone—allergic rhinitis	6.3e-05	0.000252	CcSEcCtD
Bortezomib—Syncope—Methylprednisolone—allergic rhinitis	6.29e-05	0.000252	CcSEcCtD
Bortezomib—Discomfort—Hydrocortisone—allergic rhinitis	6.27e-05	0.000251	CcSEcCtD
Bortezomib—Anaphylactic shock—Prednisolone—allergic rhinitis	6.23e-05	0.00025	CcSEcCtD
Bortezomib—Oedema—Prednisolone—allergic rhinitis	6.23e-05	0.00025	CcSEcCtD
Bortezomib—Loss of consciousness—Triamcinolone—allergic rhinitis	6.17e-05	0.000247	CcSEcCtD
Bortezomib—Loss of consciousness—Methylprednisolone—allergic rhinitis	6.16e-05	0.000247	CcSEcCtD
Bortezomib—Shock—Prednisolone—allergic rhinitis	6.13e-05	0.000246	CcSEcCtD
Bortezomib—Cough—Triamcinolone—allergic rhinitis	6.13e-05	0.000246	CcSEcCtD
Bortezomib—Anaphylactic shock—Hydrocortisone—allergic rhinitis	6.09e-05	0.000244	CcSEcCtD
Bortezomib—Oedema—Hydrocortisone—allergic rhinitis	6.09e-05	0.000244	CcSEcCtD
Bortezomib—Convulsion—Triamcinolone—allergic rhinitis	6.09e-05	0.000244	CcSEcCtD
Bortezomib—Tachycardia—Prednisolone—allergic rhinitis	6.08e-05	0.000244	CcSEcCtD
Bortezomib—Convulsion—Methylprednisolone—allergic rhinitis	6.07e-05	0.000243	CcSEcCtD
Bortezomib—Hypertension—Triamcinolone—allergic rhinitis	6.06e-05	0.000243	CcSEcCtD
Bortezomib—Hypertension—Methylprednisolone—allergic rhinitis	6.05e-05	0.000242	CcSEcCtD
Bortezomib—Infection—Hydrocortisone—allergic rhinitis	6.05e-05	0.000242	CcSEcCtD
Bortezomib—Hyperhidrosis—Prednisolone—allergic rhinitis	6.03e-05	0.000241	CcSEcCtD
Bortezomib—Shock—Hydrocortisone—allergic rhinitis	5.99e-05	0.00024	CcSEcCtD
Bortezomib—Myalgia—Triamcinolone—allergic rhinitis	5.98e-05	0.00024	CcSEcCtD
Bortezomib—Nervous system disorder—Hydrocortisone—allergic rhinitis	5.97e-05	0.000239	CcSEcCtD
Bortezomib—Myalgia—Methylprednisolone—allergic rhinitis	5.97e-05	0.000239	CcSEcCtD
Bortezomib—Arthralgia—Methylprednisolone—allergic rhinitis	5.97e-05	0.000239	CcSEcCtD
Bortezomib—Anxiety—Methylprednisolone—allergic rhinitis	5.95e-05	0.000238	CcSEcCtD
Bortezomib—Tachycardia—Hydrocortisone—allergic rhinitis	5.94e-05	0.000238	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	5.93e-05	0.000237	CcSEcCtD
Bortezomib—Skin disorder—Hydrocortisone—allergic rhinitis	5.91e-05	0.000237	CcSEcCtD
Bortezomib—Ill-defined disorder—Betamethasone—allergic rhinitis	5.91e-05	0.000237	CcSEcCtD
Bortezomib—Ill-defined disorder—Dexamethasone—allergic rhinitis	5.91e-05	0.000237	CcSEcCtD
Bortezomib—Discomfort—Triamcinolone—allergic rhinitis	5.91e-05	0.000237	CcSEcCtD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	5.9e-05	0.00155	CbGpPWpGaD
Bortezomib—Discomfort—Methylprednisolone—allergic rhinitis	5.9e-05	0.000236	CcSEcCtD
Bortezomib—Hyperhidrosis—Hydrocortisone—allergic rhinitis	5.89e-05	0.000236	CcSEcCtD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	5.84e-05	0.00154	CbGpPWpGaD
Bortezomib—Angioedema—Dexamethasone—allergic rhinitis	5.82e-05	0.000233	CcSEcCtD
Bortezomib—Angioedema—Betamethasone—allergic rhinitis	5.82e-05	0.000233	CcSEcCtD
Bortezomib—Anorexia—Hydrocortisone—allergic rhinitis	5.8e-05	0.000233	CcSEcCtD
Bortezomib—Confusional state—Methylprednisolone—allergic rhinitis	5.77e-05	0.000231	CcSEcCtD
Bortezomib—Malaise—Dexamethasone—allergic rhinitis	5.75e-05	0.00023	CcSEcCtD
Bortezomib—Malaise—Betamethasone—allergic rhinitis	5.75e-05	0.00023	CcSEcCtD
Bortezomib—Anaphylactic shock—Triamcinolone—allergic rhinitis	5.73e-05	0.00023	CcSEcCtD
Bortezomib—Oedema—Triamcinolone—allergic rhinitis	5.73e-05	0.00023	CcSEcCtD
Bortezomib—Vertigo—Betamethasone—allergic rhinitis	5.73e-05	0.000229	CcSEcCtD
Bortezomib—Vertigo—Dexamethasone—allergic rhinitis	5.73e-05	0.000229	CcSEcCtD
Bortezomib—Anaphylactic shock—Methylprednisolone—allergic rhinitis	5.72e-05	0.000229	CcSEcCtD
Bortezomib—Syncope—Betamethasone—allergic rhinitis	5.72e-05	0.000229	CcSEcCtD
Bortezomib—Syncope—Dexamethasone—allergic rhinitis	5.72e-05	0.000229	CcSEcCtD
Bortezomib—Infection—Triamcinolone—allergic rhinitis	5.7e-05	0.000228	CcSEcCtD
Bortezomib—Hypotension—Hydrocortisone—allergic rhinitis	5.69e-05	0.000228	CcSEcCtD
Bortezomib—Infection—Methylprednisolone—allergic rhinitis	5.68e-05	0.000228	CcSEcCtD
Bortezomib—PSMB8—Levonorgestrel—Hydrocortisone—allergic rhinitis	5.65e-05	0.00958	CbGdCrCtD
Bortezomib—Shock—Triamcinolone—allergic rhinitis	5.64e-05	0.000226	CcSEcCtD
Bortezomib—Insomnia—Prednisolone—allergic rhinitis	5.64e-05	0.000226	CcSEcCtD
Bortezomib—Shock—Methylprednisolone—allergic rhinitis	5.63e-05	0.000226	CcSEcCtD
Bortezomib—Nervous system disorder—Methylprednisolone—allergic rhinitis	5.61e-05	0.000225	CcSEcCtD
Bortezomib—Loss of consciousness—Dexamethasone—allergic rhinitis	5.6e-05	0.000224	CcSEcCtD
Bortezomib—Loss of consciousness—Betamethasone—allergic rhinitis	5.6e-05	0.000224	CcSEcCtD
Bortezomib—Paraesthesia—Prednisolone—allergic rhinitis	5.6e-05	0.000224	CcSEcCtD
Bortezomib—Tachycardia—Triamcinolone—allergic rhinitis	5.6e-05	0.000224	CcSEcCtD
Bortezomib—Tachycardia—Methylprednisolone—allergic rhinitis	5.58e-05	0.000224	CcSEcCtD
Bortezomib—Skin disorder—Methylprednisolone—allergic rhinitis	5.56e-05	0.000223	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	5.55e-05	0.000222	CcSEcCtD
Bortezomib—Hyperhidrosis—Triamcinolone—allergic rhinitis	5.54e-05	0.000222	CcSEcCtD
Bortezomib—Hyperhidrosis—Methylprednisolone—allergic rhinitis	5.53e-05	0.000222	CcSEcCtD
Bortezomib—PSMA1—Immune System—HLA-DQB1—allergic rhinitis	5.53e-05	0.00145	CbGpPWpGaD
Bortezomib—Convulsion—Betamethasone—allergic rhinitis	5.52e-05	0.000221	CcSEcCtD
Bortezomib—Convulsion—Dexamethasone—allergic rhinitis	5.52e-05	0.000221	CcSEcCtD
Bortezomib—Insomnia—Hydrocortisone—allergic rhinitis	5.51e-05	0.000221	CcSEcCtD
Bortezomib—Hypertension—Dexamethasone—allergic rhinitis	5.5e-05	0.000221	CcSEcCtD
Bortezomib—Hypertension—Betamethasone—allergic rhinitis	5.5e-05	0.000221	CcSEcCtD
Bortezomib—PSMD1—Immune System—HLA-DQB1—allergic rhinitis	5.5e-05	0.00145	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-DQB1—allergic rhinitis	5.47e-05	0.00144	CbGpPWpGaD
Bortezomib—Paraesthesia—Hydrocortisone—allergic rhinitis	5.47e-05	0.000219	CcSEcCtD
Bortezomib—Myalgia—Betamethasone—allergic rhinitis	5.43e-05	0.000217	CcSEcCtD
Bortezomib—Myalgia—Dexamethasone—allergic rhinitis	5.43e-05	0.000217	CcSEcCtD
Bortezomib—PSMB5—Immune System—IL5—allergic rhinitis	5.41e-05	0.00142	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL5—allergic rhinitis	5.41e-05	0.00142	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL5—allergic rhinitis	5.41e-05	0.00142	CbGpPWpGaD
Bortezomib—Anxiety—Dexamethasone—allergic rhinitis	5.41e-05	0.000217	CcSEcCtD
Bortezomib—Anxiety—Betamethasone—allergic rhinitis	5.41e-05	0.000217	CcSEcCtD
Bortezomib—Discomfort—Dexamethasone—allergic rhinitis	5.36e-05	0.000215	CcSEcCtD
Bortezomib—Discomfort—Betamethasone—allergic rhinitis	5.36e-05	0.000215	CcSEcCtD
Bortezomib—PSMB2—Signaling Pathways—CYSLTR1—allergic rhinitis	5.36e-05	0.00141	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CYSLTR1—allergic rhinitis	5.36e-05	0.00141	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CYSLTR1—allergic rhinitis	5.36e-05	0.00141	CbGpPWpGaD
Bortezomib—Dyspepsia—Hydrocortisone—allergic rhinitis	5.36e-05	0.000215	CcSEcCtD
Bortezomib—Hypotension—Methylprednisolone—allergic rhinitis	5.34e-05	0.000214	CcSEcCtD
Bortezomib—PSMB8—Immune System—IL5—allergic rhinitis	5.33e-05	0.0014	CbGpPWpGaD
Bortezomib—Pain—Prednisolone—allergic rhinitis	5.33e-05	0.000214	CcSEcCtD
Bortezomib—Decreased appetite—Hydrocortisone—allergic rhinitis	5.29e-05	0.000212	CcSEcCtD
Bortezomib—PSMB8—Signaling Pathways—CYSLTR1—allergic rhinitis	5.28e-05	0.00139	CbGpPWpGaD
Bortezomib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	5.26e-05	0.000211	CcSEcCtD
Bortezomib—Fatigue—Hydrocortisone—allergic rhinitis	5.25e-05	0.00021	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	5.22e-05	0.000209	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	5.21e-05	0.000209	CcSEcCtD
Bortezomib—Pain—Hydrocortisone—allergic rhinitis	5.21e-05	0.000209	CcSEcCtD
Bortezomib—Anaphylactic shock—Betamethasone—allergic rhinitis	5.2e-05	0.000208	CcSEcCtD
Bortezomib—Oedema—Dexamethasone—allergic rhinitis	5.2e-05	0.000208	CcSEcCtD
Bortezomib—Oedema—Betamethasone—allergic rhinitis	5.2e-05	0.000208	CcSEcCtD
Bortezomib—Anaphylactic shock—Dexamethasone—allergic rhinitis	5.2e-05	0.000208	CcSEcCtD
Bortezomib—Insomnia—Triamcinolone—allergic rhinitis	5.19e-05	0.000208	CcSEcCtD
Bortezomib—PSMB2—Signaling Pathways—CCL11—allergic rhinitis	5.18e-05	0.00136	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCL11—allergic rhinitis	5.18e-05	0.00136	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCL11—allergic rhinitis	5.18e-05	0.00136	CbGpPWpGaD
Bortezomib—Insomnia—Methylprednisolone—allergic rhinitis	5.17e-05	0.000207	CcSEcCtD
Bortezomib—Infection—Betamethasone—allergic rhinitis	5.17e-05	0.000207	CcSEcCtD
Bortezomib—Infection—Dexamethasone—allergic rhinitis	5.17e-05	0.000207	CcSEcCtD
Bortezomib—Paraesthesia—Triamcinolone—allergic rhinitis	5.15e-05	0.000206	CcSEcCtD
Bortezomib—Feeling abnormal—Prednisolone—allergic rhinitis	5.14e-05	0.000206	CcSEcCtD
Bortezomib—Paraesthesia—Methylprednisolone—allergic rhinitis	5.14e-05	0.000206	CcSEcCtD
Bortezomib—Shock—Betamethasone—allergic rhinitis	5.12e-05	0.000205	CcSEcCtD
Bortezomib—Shock—Dexamethasone—allergic rhinitis	5.12e-05	0.000205	CcSEcCtD
Bortezomib—Dyspnoea—Triamcinolone—allergic rhinitis	5.11e-05	0.000205	CcSEcCtD
Bortezomib—PSMB8—Signaling Pathways—CCL11—allergic rhinitis	5.1e-05	0.00134	CbGpPWpGaD
Bortezomib—Nervous system disorder—Dexamethasone—allergic rhinitis	5.1e-05	0.000204	CcSEcCtD
Bortezomib—Nervous system disorder—Betamethasone—allergic rhinitis	5.1e-05	0.000204	CcSEcCtD
Bortezomib—Thrombocytopenia—Betamethasone—allergic rhinitis	5.09e-05	0.000204	CcSEcCtD
Bortezomib—Thrombocytopenia—Dexamethasone—allergic rhinitis	5.09e-05	0.000204	CcSEcCtD
Bortezomib—Tachycardia—Dexamethasone—allergic rhinitis	5.08e-05	0.000203	CcSEcCtD
Bortezomib—Tachycardia—Betamethasone—allergic rhinitis	5.08e-05	0.000203	CcSEcCtD
Bortezomib—Dyspepsia—Triamcinolone—allergic rhinitis	5.05e-05	0.000202	CcSEcCtD
Bortezomib—PSMB2—Adaptive Immune System—ICAM1—allergic rhinitis	5.04e-05	0.00133	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—ICAM1—allergic rhinitis	5.04e-05	0.00133	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—ICAM1—allergic rhinitis	5.04e-05	0.00133	CbGpPWpGaD
Bortezomib—Dyspepsia—Methylprednisolone—allergic rhinitis	5.04e-05	0.000202	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Hydrocortisone—allergic rhinitis	5.03e-05	0.00853	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Hydrocortisone—allergic rhinitis	5.03e-05	0.00853	CbGdCrCtD
Bortezomib—Hyperhidrosis—Dexamethasone—allergic rhinitis	5.03e-05	0.000202	CcSEcCtD
Bortezomib—Hyperhidrosis—Betamethasone—allergic rhinitis	5.03e-05	0.000202	CcSEcCtD
Bortezomib—Feeling abnormal—Hydrocortisone—allergic rhinitis	5.02e-05	0.000201	CcSEcCtD
Bortezomib—PSMA1—Gene Expression—SMAD3—allergic rhinitis	5e-05	0.00131	CbGpPWpGaD
Bortezomib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	4.98e-05	0.000199	CcSEcCtD
Bortezomib—PSMD1—Gene Expression—SMAD3—allergic rhinitis	4.97e-05	0.00131	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—ICAM1—allergic rhinitis	4.97e-05	0.00131	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TAC1—allergic rhinitis	4.96e-05	0.00131	CbGpPWpGaD
Bortezomib—Anorexia—Dexamethasone—allergic rhinitis	4.96e-05	0.000199	CcSEcCtD
Bortezomib—Anorexia—Betamethasone—allergic rhinitis	4.96e-05	0.000199	CcSEcCtD
Bortezomib—Urticaria—Prednisolone—allergic rhinitis	4.95e-05	0.000198	CcSEcCtD
Bortezomib—PSMD2—Gene Expression—SMAD3—allergic rhinitis	4.95e-05	0.0013	CbGpPWpGaD
Bortezomib—Fatigue—Triamcinolone—allergic rhinitis	4.94e-05	0.000198	CcSEcCtD
Bortezomib—PSMD1—Signaling Pathways—TAC1—allergic rhinitis	4.94e-05	0.0013	CbGpPWpGaD
Bortezomib—Fatigue—Methylprednisolone—allergic rhinitis	4.93e-05	0.000198	CcSEcCtD
Bortezomib—PSMD2—Signaling Pathways—TAC1—allergic rhinitis	4.92e-05	0.00129	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	4.92e-05	0.00129	CbGpPWpGaD
Bortezomib—Pain—Triamcinolone—allergic rhinitis	4.9e-05	0.000196	CcSEcCtD
Bortezomib—PSMA1—Adaptive Immune System—CD4—allergic rhinitis	4.89e-05	0.00129	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CD4—allergic rhinitis	4.86e-05	0.00128	CbGpPWpGaD
Bortezomib—Hypotension—Dexamethasone—allergic rhinitis	4.86e-05	0.000195	CcSEcCtD
Bortezomib—Hypotension—Betamethasone—allergic rhinitis	4.86e-05	0.000195	CcSEcCtD
Bortezomib—PSMD2—Adaptive Immune System—CD4—allergic rhinitis	4.84e-05	0.00127	CbGpPWpGaD
Bortezomib—Urticaria—Hydrocortisone—allergic rhinitis	4.84e-05	0.000194	CcSEcCtD
Bortezomib—Body temperature increased—Hydrocortisone—allergic rhinitis	4.81e-05	0.000193	CcSEcCtD
Bortezomib—Abdominal pain—Hydrocortisone—allergic rhinitis	4.81e-05	0.000193	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Methylprednisolone—allergic rhinitis	4.75e-05	0.00805	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Methylprednisolone—allergic rhinitis	4.75e-05	0.00805	CbGdCrCtD
Bortezomib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	4.74e-05	0.00019	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	4.74e-05	0.00019	CcSEcCtD
Bortezomib—Feeling abnormal—Triamcinolone—allergic rhinitis	4.72e-05	0.000189	CcSEcCtD
Bortezomib—Feeling abnormal—Methylprednisolone—allergic rhinitis	4.71e-05	0.000189	CcSEcCtD
Bortezomib—Insomnia—Betamethasone—allergic rhinitis	4.7e-05	0.000189	CcSEcCtD
Bortezomib—Insomnia—Dexamethasone—allergic rhinitis	4.7e-05	0.000189	CcSEcCtD
Bortezomib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	4.68e-05	0.000187	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Dexamethasone—allergic rhinitis	4.67e-05	0.00792	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Betamethasone—allergic rhinitis	4.67e-05	0.00792	CbGdCrCtD
Bortezomib—Paraesthesia—Dexamethasone—allergic rhinitis	4.67e-05	0.000187	CcSEcCtD
Bortezomib—Paraesthesia—Betamethasone—allergic rhinitis	4.67e-05	0.000187	CcSEcCtD
Bortezomib—PSMA1—Disease—SMAD3—allergic rhinitis	4.64e-05	0.00122	CbGpPWpGaD
Bortezomib—PSMD1—Disease—SMAD3—allergic rhinitis	4.62e-05	0.00122	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL5—allergic rhinitis	4.61e-05	0.00121	CbGpPWpGaD
Bortezomib—PSMD2—Disease—SMAD3—allergic rhinitis	4.59e-05	0.00121	CbGpPWpGaD
Bortezomib—Hypersensitivity—Prednisolone—allergic rhinitis	4.59e-05	0.000184	CcSEcCtD
Bortezomib—PSMD1—Signaling Pathways—IL5—allergic rhinitis	4.59e-05	0.00121	CbGpPWpGaD
Bortezomib—Dyspepsia—Dexamethasone—allergic rhinitis	4.58e-05	0.000183	CcSEcCtD
Bortezomib—Dyspepsia—Betamethasone—allergic rhinitis	4.58e-05	0.000183	CcSEcCtD
Bortezomib—PSMD2—Signaling Pathways—IL5—allergic rhinitis	4.57e-05	0.0012	CbGpPWpGaD
Bortezomib—PSMB8—Dexamethasone—Triamcinolone—allergic rhinitis	4.57e-05	0.00774	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Triamcinolone—allergic rhinitis	4.57e-05	0.00774	CbGdCrCtD
Bortezomib—Urticaria—Triamcinolone—allergic rhinitis	4.55e-05	0.000182	CcSEcCtD
Bortezomib—Urticaria—Methylprednisolone—allergic rhinitis	4.54e-05	0.000182	CcSEcCtD
Bortezomib—Body temperature increased—Triamcinolone—allergic rhinitis	4.53e-05	0.000182	CcSEcCtD
Bortezomib—Abdominal pain—Methylprednisolone—allergic rhinitis	4.52e-05	0.000181	CcSEcCtD
Bortezomib—Decreased appetite—Betamethasone—allergic rhinitis	4.52e-05	0.000181	CcSEcCtD
Bortezomib—Decreased appetite—Dexamethasone—allergic rhinitis	4.52e-05	0.000181	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	4.49e-05	0.00018	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	4.49e-05	0.00018	CcSEcCtD
Bortezomib—Hypersensitivity—Hydrocortisone—allergic rhinitis	4.49e-05	0.00018	CcSEcCtD
Bortezomib—Fatigue—Dexamethasone—allergic rhinitis	4.48e-05	0.00018	CcSEcCtD
Bortezomib—Fatigue—Betamethasone—allergic rhinitis	4.48e-05	0.00018	CcSEcCtD
Bortezomib—Pain—Dexamethasone—allergic rhinitis	4.45e-05	0.000178	CcSEcCtD
Bortezomib—Pain—Betamethasone—allergic rhinitis	4.45e-05	0.000178	CcSEcCtD
Bortezomib—Asthenia—Hydrocortisone—allergic rhinitis	4.37e-05	0.000175	CcSEcCtD
Bortezomib—Pruritus—Hydrocortisone—allergic rhinitis	4.31e-05	0.000173	CcSEcCtD
Bortezomib—Feeling abnormal—Betamethasone—allergic rhinitis	4.29e-05	0.000172	CcSEcCtD
Bortezomib—Feeling abnormal—Dexamethasone—allergic rhinitis	4.29e-05	0.000172	CcSEcCtD
Bortezomib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	4.25e-05	0.00017	CcSEcCtD
Bortezomib—Gastrointestinal pain—Betamethasone—allergic rhinitis	4.25e-05	0.00017	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Prednisolone—allergic rhinitis	4.23e-05	0.00717	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Prednisolone—allergic rhinitis	4.23e-05	0.00717	CbGdCrCtD
Bortezomib—Hypersensitivity—Triamcinolone—allergic rhinitis	4.22e-05	0.000169	CcSEcCtD
Bortezomib—Hypersensitivity—Methylprednisolone—allergic rhinitis	4.21e-05	0.000169	CcSEcCtD
Bortezomib—PSMA1—Adaptive Immune System—NFKB1—allergic rhinitis	4.21e-05	0.00111	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—NFKB1—allergic rhinitis	4.19e-05	0.0011	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HLA-DQB1—allergic rhinitis	4.19e-05	0.0011	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-DQB1—allergic rhinitis	4.19e-05	0.0011	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-DQB1—allergic rhinitis	4.19e-05	0.0011	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—NFKB1—allergic rhinitis	4.17e-05	0.0011	CbGpPWpGaD
Bortezomib—Diarrhoea—Hydrocortisone—allergic rhinitis	4.17e-05	0.000167	CcSEcCtD
Bortezomib—Urticaria—Dexamethasone—allergic rhinitis	4.13e-05	0.000166	CcSEcCtD
Bortezomib—Urticaria—Betamethasone—allergic rhinitis	4.13e-05	0.000166	CcSEcCtD
Bortezomib—PSMB8—Immune System—HLA-DQB1—allergic rhinitis	4.13e-05	0.00109	CbGpPWpGaD
Bortezomib—Dizziness—Prednisolone—allergic rhinitis	4.12e-05	0.000165	CcSEcCtD
Bortezomib—Asthenia—Triamcinolone—allergic rhinitis	4.11e-05	0.000165	CcSEcCtD
Bortezomib—Abdominal pain—Betamethasone—allergic rhinitis	4.11e-05	0.000165	CcSEcCtD
Bortezomib—Body temperature increased—Betamethasone—allergic rhinitis	4.11e-05	0.000165	CcSEcCtD
Bortezomib—Body temperature increased—Dexamethasone—allergic rhinitis	4.11e-05	0.000165	CcSEcCtD
Bortezomib—Abdominal pain—Dexamethasone—allergic rhinitis	4.11e-05	0.000165	CcSEcCtD
Bortezomib—Asthenia—Methylprednisolone—allergic rhinitis	4.1e-05	0.000164	CcSEcCtD
Bortezomib—Pruritus—Triamcinolone—allergic rhinitis	4.06e-05	0.000163	CcSEcCtD
Bortezomib—Pruritus—Methylprednisolone—allergic rhinitis	4.05e-05	0.000162	CcSEcCtD
Bortezomib—PSMA1—Immune System—ICAM1—allergic rhinitis	4.03e-05	0.00106	CbGpPWpGaD
Bortezomib—Dizziness—Hydrocortisone—allergic rhinitis	4.03e-05	0.000161	CcSEcCtD
Bortezomib—PSMD1—Immune System—ICAM1—allergic rhinitis	4.01e-05	0.00106	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—ICAM1—allergic rhinitis	3.99e-05	0.00105	CbGpPWpGaD
Bortezomib—Rash—Prednisolone—allergic rhinitis	3.93e-05	0.000158	CcSEcCtD
Bortezomib—Dermatitis—Prednisolone—allergic rhinitis	3.93e-05	0.000157	CcSEcCtD
Bortezomib—Diarrhoea—Methylprednisolone—allergic rhinitis	3.91e-05	0.000157	CcSEcCtD
Bortezomib—Headache—Prednisolone—allergic rhinitis	3.91e-05	0.000156	CcSEcCtD
Bortezomib—Vomiting—Hydrocortisone—allergic rhinitis	3.87e-05	0.000155	CcSEcCtD
Bortezomib—Rash—Hydrocortisone—allergic rhinitis	3.84e-05	0.000154	CcSEcCtD
Bortezomib—Dermatitis—Hydrocortisone—allergic rhinitis	3.84e-05	0.000154	CcSEcCtD
Bortezomib—Headache—Hydrocortisone—allergic rhinitis	3.81e-05	0.000153	CcSEcCtD
Bortezomib—Dizziness—Triamcinolone—allergic rhinitis	3.79e-05	0.000152	CcSEcCtD
Bortezomib—PSMB2—Gene Expression—SMAD3—allergic rhinitis	3.79e-05	0.000997	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—SMAD3—allergic rhinitis	3.79e-05	0.000997	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—SMAD3—allergic rhinitis	3.79e-05	0.000997	CbGpPWpGaD
Bortezomib—Dizziness—Methylprednisolone—allergic rhinitis	3.78e-05	0.000152	CcSEcCtD
Bortezomib—PSMB1—Signaling Pathways—TAC1—allergic rhinitis	3.76e-05	0.00099	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TAC1—allergic rhinitis	3.76e-05	0.00099	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TAC1—allergic rhinitis	3.76e-05	0.00099	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—SMAD3—allergic rhinitis	3.73e-05	0.000983	CbGpPWpGaD
Bortezomib—Asthenia—Dexamethasone—allergic rhinitis	3.73e-05	0.00015	CcSEcCtD
Bortezomib—Asthenia—Betamethasone—allergic rhinitis	3.73e-05	0.00015	CcSEcCtD
Bortezomib—PSMB8—Signaling Pathways—TAC1—allergic rhinitis	3.71e-05	0.000976	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CD4—allergic rhinitis	3.7e-05	0.000975	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CD4—allergic rhinitis	3.7e-05	0.000975	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CD4—allergic rhinitis	3.7e-05	0.000975	CbGpPWpGaD
Bortezomib—Nausea—Prednisolone—allergic rhinitis	3.7e-05	0.000148	CcSEcCtD
Bortezomib—Pruritus—Dexamethasone—allergic rhinitis	3.68e-05	0.000147	CcSEcCtD
Bortezomib—Pruritus—Betamethasone—allergic rhinitis	3.68e-05	0.000147	CcSEcCtD
Bortezomib—PSMB8—Adaptive Immune System—CD4—allergic rhinitis	3.65e-05	0.000961	CbGpPWpGaD
Bortezomib—Vomiting—Triamcinolone—allergic rhinitis	3.64e-05	0.000146	CcSEcCtD
Bortezomib—Vomiting—Methylprednisolone—allergic rhinitis	3.64e-05	0.000146	CcSEcCtD
Bortezomib—Nausea—Hydrocortisone—allergic rhinitis	3.62e-05	0.000145	CcSEcCtD
Bortezomib—Rash—Triamcinolone—allergic rhinitis	3.61e-05	0.000145	CcSEcCtD
Bortezomib—Dermatitis—Triamcinolone—allergic rhinitis	3.61e-05	0.000145	CcSEcCtD
Bortezomib—Rash—Methylprednisolone—allergic rhinitis	3.61e-05	0.000145	CcSEcCtD
Bortezomib—Dermatitis—Methylprednisolone—allergic rhinitis	3.6e-05	0.000144	CcSEcCtD
Bortezomib—Headache—Triamcinolone—allergic rhinitis	3.59e-05	0.000144	CcSEcCtD
Bortezomib—Headache—Methylprednisolone—allergic rhinitis	3.58e-05	0.000144	CcSEcCtD
Bortezomib—Diarrhoea—Dexamethasone—allergic rhinitis	3.56e-05	0.000143	CcSEcCtD
Bortezomib—Diarrhoea—Betamethasone—allergic rhinitis	3.56e-05	0.000143	CcSEcCtD
Bortezomib—PSMB2—Disease—SMAD3—allergic rhinitis	3.51e-05	0.000925	CbGpPWpGaD
Bortezomib—PSMB1—Disease—SMAD3—allergic rhinitis	3.51e-05	0.000925	CbGpPWpGaD
Bortezomib—PSMB5—Disease—SMAD3—allergic rhinitis	3.51e-05	0.000925	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL5—allergic rhinitis	3.5e-05	0.000921	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL5—allergic rhinitis	3.5e-05	0.000921	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL5—allergic rhinitis	3.5e-05	0.000921	CbGpPWpGaD
Bortezomib—PSMB8—Disease—SMAD3—allergic rhinitis	3.47e-05	0.000912	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL5—allergic rhinitis	3.45e-05	0.000908	CbGpPWpGaD
Bortezomib—Dizziness—Betamethasone—allergic rhinitis	3.44e-05	0.000138	CcSEcCtD
Bortezomib—Dizziness—Dexamethasone—allergic rhinitis	3.44e-05	0.000138	CcSEcCtD
Bortezomib—Nausea—Triamcinolone—allergic rhinitis	3.41e-05	0.000136	CcSEcCtD
Bortezomib—Nausea—Methylprednisolone—allergic rhinitis	3.4e-05	0.000136	CcSEcCtD
Bortezomib—Vomiting—Dexamethasone—allergic rhinitis	3.31e-05	0.000133	CcSEcCtD
Bortezomib—Vomiting—Betamethasone—allergic rhinitis	3.31e-05	0.000133	CcSEcCtD
Bortezomib—Rash—Betamethasone—allergic rhinitis	3.28e-05	0.000131	CcSEcCtD
Bortezomib—Rash—Dexamethasone—allergic rhinitis	3.28e-05	0.000131	CcSEcCtD
Bortezomib—Dermatitis—Dexamethasone—allergic rhinitis	3.28e-05	0.000131	CcSEcCtD
Bortezomib—Dermatitis—Betamethasone—allergic rhinitis	3.28e-05	0.000131	CcSEcCtD
Bortezomib—Headache—Betamethasone—allergic rhinitis	3.26e-05	0.000131	CcSEcCtD
Bortezomib—Headache—Dexamethasone—allergic rhinitis	3.26e-05	0.000131	CcSEcCtD
Bortezomib—PSMA1—Signaling Pathways—SMAD3—allergic rhinitis	3.25e-05	0.000855	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SMAD3—allergic rhinitis	3.23e-05	0.000851	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SMAD3—allergic rhinitis	3.22e-05	0.000847	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—NFKB1—allergic rhinitis	3.19e-05	0.00084	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—NFKB1—allergic rhinitis	3.19e-05	0.00084	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—NFKB1—allergic rhinitis	3.19e-05	0.00084	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—NFKB1—allergic rhinitis	3.15e-05	0.000828	CbGpPWpGaD
Bortezomib—Nausea—Betamethasone—allergic rhinitis	3.09e-05	0.000124	CcSEcCtD
Bortezomib—Nausea—Dexamethasone—allergic rhinitis	3.09e-05	0.000124	CcSEcCtD
Bortezomib—PSMB2—Immune System—ICAM1—allergic rhinitis	3.06e-05	0.000805	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—ICAM1—allergic rhinitis	3.06e-05	0.000805	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—ICAM1—allergic rhinitis	3.06e-05	0.000805	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—ICAM1—allergic rhinitis	3.01e-05	0.000793	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD4—allergic rhinitis	2.96e-05	0.00078	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD4—allergic rhinitis	2.95e-05	0.000776	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD4—allergic rhinitis	2.94e-05	0.000773	CbGpPWpGaD
Bortezomib—PSMA1—Disease—CD4—allergic rhinitis	2.74e-05	0.00072	CbGpPWpGaD
Bortezomib—PSMD1—Disease—CD4—allergic rhinitis	2.72e-05	0.000717	CbGpPWpGaD
Bortezomib—PSMD2—Disease—CD4—allergic rhinitis	2.71e-05	0.000713	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—NFKB1—allergic rhinitis	2.55e-05	0.000672	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—NFKB1—allergic rhinitis	2.54e-05	0.000669	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—NFKB1—allergic rhinitis	2.53e-05	0.000666	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SMAD3—allergic rhinitis	2.46e-05	0.000648	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SMAD3—allergic rhinitis	2.46e-05	0.000648	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SMAD3—allergic rhinitis	2.46e-05	0.000648	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SMAD3—allergic rhinitis	2.43e-05	0.000639	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD4—allergic rhinitis	2.25e-05	0.000591	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD4—allergic rhinitis	2.25e-05	0.000591	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD4—allergic rhinitis	2.25e-05	0.000591	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD4—allergic rhinitis	2.21e-05	0.000583	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CD4—allergic rhinitis	2.07e-05	0.000546	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CD4—allergic rhinitis	2.07e-05	0.000546	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CD4—allergic rhinitis	2.07e-05	0.000546	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CD4—allergic rhinitis	2.04e-05	0.000538	CbGpPWpGaD
Bortezomib—PSMA1—Disease—TGFB1—allergic rhinitis	1.96e-05	0.000517	CbGpPWpGaD
Bortezomib—PSMD1—Disease—TGFB1—allergic rhinitis	1.95e-05	0.000514	CbGpPWpGaD
Bortezomib—PSMD2—Disease—TGFB1—allergic rhinitis	1.95e-05	0.000512	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—NFKB1—allergic rhinitis	1.94e-05	0.000509	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—NFKB1—allergic rhinitis	1.94e-05	0.000509	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—NFKB1—allergic rhinitis	1.94e-05	0.000509	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—NFKB1—allergic rhinitis	1.91e-05	0.000502	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NFKB1—allergic rhinitis	1.65e-05	0.000435	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NFKB1—allergic rhinitis	1.64e-05	0.000433	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NFKB1—allergic rhinitis	1.64e-05	0.00043	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TGFB1—allergic rhinitis	1.49e-05	0.000392	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TGFB1—allergic rhinitis	1.49e-05	0.000392	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TGFB1—allergic rhinitis	1.49e-05	0.000392	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TGFB1—allergic rhinitis	1.47e-05	0.000386	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TGFB1—allergic rhinitis	1.38e-05	0.000362	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TGFB1—allergic rhinitis	1.37e-05	0.00036	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TGFB1—allergic rhinitis	1.36e-05	0.000359	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NFKB1—allergic rhinitis	1.25e-05	0.000329	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NFKB1—allergic rhinitis	1.25e-05	0.000329	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NFKB1—allergic rhinitis	1.25e-05	0.000329	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NFKB1—allergic rhinitis	1.23e-05	0.000325	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TGFB1—allergic rhinitis	1.04e-05	0.000274	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TGFB1—allergic rhinitis	1.04e-05	0.000274	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TGFB1—allergic rhinitis	1.04e-05	0.000274	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TGFB1—allergic rhinitis	1.03e-05	0.00027	CbGpPWpGaD
